Latest News and Press Releases

NBI-1117568 is an oral, selective muscarinic M4 receptor agonist advancing through Phase 2 clinical development under a multi-program collaboration with Neurocrine BiosciencesSuccessful completion of...

BOTHELL, Wash., April 04, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...

CAMBRIDGE, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...

New York, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) has announced the winners of its 2021 Klerman and Freedman Prizes, which recognize exceptional...

CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...

NEW YORK, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Dr. Stephen I. Kramer, Professor Emeritus at Wake Forest Baptist Health Sciences and Field Representative/Physician Surveyor at The Joint Commission, has...

NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Dr. Michael Irwin, Director and Cousins Distinguished Professor of Psychiatry at UCLA Medical Center, has been selected to join the Physician Board...

NEW YORK, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Dr. Neil Kaye, Forensic Psychiatrist, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and...